8-K: Genworth Q4 2025: Enact Strong, LTC Losses Weigh on Results
Quarterly Report
Genworth Financial reports mixed Q4 2025 results with strong performance from its Enact mortgage insurance segment offset by significant losses in its Closed Block long-term care insurance.
Summary
- Net income available to common stockholders for Q4 2025 was $2 million, a significant decrease from $116 million in Q3 2025.
- Adjusted operating income available to common stockholders for Q4 2025 was $8 million, down from $17 million in Q3 2025 and $15 million in Q4 2024.
- For the full year 2025, net income was $223 million ($0.54 per diluted share) and adjusted operating income was $144 million ($0.35 per diluted share).
- The Enact segment reported strong adjusted operating income of $146 million in Q4 2025, up from $134 million in Q3 2025 and $137 million in Q4 2024.
- Enact distributed $127 million in capital returns to Genworth in Q4 2025 and maintained a strong estimated PMIERs sufficiency ratio of 162%, $1,919 million above requirements.
- The Closed Block segment reported an adjusted operating loss of $(114) million in Q4 2025, primarily driven by a $(159) million loss in long-term care insurance.
- Long-term care insurance losses were due to unfavorable actual-to-expected experience of $124 million pre-tax (higher claims, lower terminations) and unfavorable assumption updates of $47 million pre-tax.
- Life insurance within the Closed Block generated $13 million in income, benefiting from favorable interest rate assumption updates of $15 million pre-tax.
- Annuities within the Closed Block generated $32 million in income, reflecting favorable annual assumption updates of $25 million pre-tax, primarily related to mortality.
- Holding company cash and liquid assets decreased to $234 million at quarter-end, including $127 million held for future obligations.
- Genworth executed $94 million in share repurchases in Q4 2025, contributing to $245 million in 2025 and $790 million since the program's inception.
- The company completed the acquisition of Seniorly, Inc. for $15 million in cash to advance its CareScout strategy.
- CareScout Insurance (Care Assurance) launched in October 2025 and was live in 39 states by December 31, 2025.
- The company changed its reportable segments in Q4 2025 to Enact, Closed Block, and Corporate and Other to better align with business management.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a mixed quarter. While Enact continues to perform strongly and strategic initiatives like CareScout are progressing, the significant decline in consolidated net income and adjusted operating income, primarily driven by substantial losses in the long-term care segment and investment losses, weighs heavily on overall performance.
Positives
- Enact segment delivered strong adjusted operating income of $146 million in Q4 2025, an increase from prior periods.
- Enact distributed $127 million in capital returns to Genworth in Q4 2025, demonstrating its cash-generating ability.
- Enact's estimated PMIERs sufficiency ratio remains strong at 162%, with $1,919 million above requirements.
- Enact's primary new insurance written (NIW) increased 8% from the prior year to $14,386 million in Q4 2025.
- Enact's primary insurance in-force grew 2% year-over-year to $273.1 billion.
- Life insurance within the Closed Block reported income of $13 million, driven by favorable interest rate assumption updates of $15 million pre-tax.
- Annuities within the Closed Block reported income of $32 million, reflecting favorable assumption updates of $25 million pre-tax, primarily related to mortality.
- Continued progress on the LTC Multi-Year Rate Action Plan (MYRAP) with $100 million of gross incremental premium approvals in Q4 2025, contributing to an estimated $34.5 billion net present value achieved since 2012.
- Successful launch and buildout of CareScout insurance offerings (Care Assurance) in 39 states by year-end.
- Acquisition of Seniorly, Inc. for $15 million in cash to advance CareScout's strategic initiatives.
- Executed $94 million in share repurchases in Q4 2025, totaling $790 million since the program's inception, indicating a commitment to shareholder returns.
- Legacy insurance companies maintained a strong estimated RBC ratio of 300%.
Negatives
- Consolidated net income for Q4 2025 was $2 million, a substantial decline from $116 million in Q3 2025.
- Consolidated adjusted operating income for Q4 2025 was $8 million, significantly lower than $17 million in Q3 2025 and $15 million in Q4 2024.
- Net investment income decreased to $620 million in Q4 2025, primarily due to lower income from limited partnerships.
- Net investment losses, net of taxes, negatively impacted net income by $31 million in Q4 2025.
- The Closed Block segment reported an adjusted operating loss of $(114) million, which worsened from $(96) million in Q3 2025 and $(99) million in Q4 2024.
- Long-term care insurance within the Closed Block incurred a significant loss of $(159) million, primarily due to $124 million pre-tax from higher claims and lower terminations, and $47 million pre-tax from unfavorable assumption updates.
- Holding company cash and liquid assets decreased to $234 million at Q4 2025 end from $254 million in Q3 2025 and $294 million in Q4 2024.
- The estimated GLIC consolidated RBC ratio decreased to 300% from 306% in Q4 2024, driven by higher required capital due to the growth of the limited partnership portfolio.
- Corporate and Other adjusted operating loss increased to $(24) million, primarily due to continued investment in CareScout and debt service.
Risks
- Inability to successfully launch new lines of business, including long-term care insurance and other products/services with CareScout.
- Failure to maintain the self-sustainability of legacy insurance subsidiaries, including due to the inability to achieve desired levels of in-force management actions and/or delays in future premium rate increases and benefit reductions.
- Other regulatory actions negatively impacting life insurance businesses.
- Inaccuracies or changes in estimates, assumptions, methodologies, valuations, projections, and/or models, which could result in inadequate reserves or other adverse results.
- Impact on holding company liquidity caused by an inability to receive dividends or any other returns of capital from Enact Holdings, and limited sources of capital and financing.
- Impact on any potential recovery in the AXA and Santander litigation resulting from a successful appeal, significant delays, or any other adverse development.
- Adverse changes to the structure or requirements of Federal National Mortgage Association (Fannie Mae), Federal Home Loan Mortgage Corporation (Freddie Mac) or the U.S. mortgage insurance market.
- An increase in the number of loans insured through federal government mortgage insurance programs.
- The inability of Enact Holdings and/or its U.S. mortgage insurance subsidiaries to continue to meet the requirements mandated by PMIERs (or any adverse changes thereto), or minimum statutory capital requirements.
- Changes in economic, market, and political conditions, labor shortages, and fluctuating interest rates, potentially leading to a recession or decline in home prices.
- An increase in the cost of care impacting the company's long-term care insurance products.
- Downgrades in financial strength and credit ratings and potential adverse impacts to liquidity.
- Counterparty credit risks; defaults by counterparties to reinsurance arrangements or derivative instruments.
- Defaults or other events impacting the value of invested assets.
- Changes in tax rates or tax laws, or changes in accounting and reporting standards.
- Litigation and regulatory investigations or other actions, including commercial and contractual disputes.
- The inability to retain, attract, and motivate qualified employees or senior management.
- Changes in the composition of Enact Holdings business or undue concentration by customer or geographic region.
- The impact from deficiencies in disclosure controls and procedures or internal control over financial reporting.
- The occurrence of natural or man-made disasters, including geopolitical tensions and war, a public health emergency, or climate change.
- The inability to effectively manage information technology systems (including artificial intelligence), cyber incidents, or other failures, disruptions, or security breaches.
- The inability of third-party vendors to meet their obligations to the company.
- The lack of availability, affordability, or adequacy of reinsurance to protect the company against losses.
- A decrease in the volume of high loan-to-value home mortgage originations or an increase in the volume of mortgage insurance cancellations.
- Unanticipated claims resulting from Enact Holdings delegated underwriting and loss mitigation programs.
- The impact of medical advances such as genetic research and diagnostic imaging, emerging new technology, including artificial intelligence and related legislation.
Future Outlook
Management expects to continue executing against strategic priorities, including advancing CareScout's strategy with further buildout of insurance offerings and disciplined management of legacy insurance businesses to deliver long-term value. Enact has authorized a new share repurchase program of up to $500 million and an excess of loss reinsurance agreement covering the 2027 book year. The company's forward-looking statements caution that quarterly adverse variances between actual and expected experience could persist, potentially leading to future remeasurement losses in its long-term care insurance products.
Management Comments
- Tom McInerney, President & CEO: "Genworth delivered strong results in 2025 as we continued to execute against our strategic priorities."
- Tom McInerney, President & CEO: "We took major steps to advance CareScouts strategy, with nationwide expansion of the CareScout Quality Network, the launch of Care Plans, our new innovative consumer-facing solution, along with the launch and continued buildout of our CareScout insurance offerings."
- Tom McInerney, President & CEO: "With Enact as a durable source of cash flows, a growing and increasingly integrated CareScout platform, and disciplined management of our legacy insurance businesses, we are delivering long-term value for shareholders while supporting millions of families navigating the aging journey."
Industry Context
StockSavvy.ai notes that Genworth's strategic focus on its CareScout platform aligns with the growing demand for aging care services and long-term care planning driven by an aging demographic. The Enact mortgage insurance segment operates within the U.S. housing market, which is influenced by interest rates and economic conditions. The company's management of its Closed Block legacy insurance businesses, particularly through in-force rate actions, reflects a common industry approach to optimize profitability and capital adequacy for mature, capital-intensive insurance portfolios.
Comparison to Industry Standards
- The filing provides internal capital adequacy metrics such as Enact's PMIERs sufficiency ratio of 162% and the legacy insurance companies' estimated RBC ratio of 300%.
- No specific comparable companies, projects, or external industry benchmarks are detailed in the filing to assess these results against global industry standards.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Segment Reporting Structure Change | Beginning in the fourth quarter of 2025, the company changed its reportable segments to Enact, Closed Block, and Corporate and Other. This change better aligns with how the business is currently managed and its strategic priorities, including maintaining self-sustaining legacy insurance subsidiaries. | Q4 2025 | Enhances understanding of business performance and better aligns with strategic priorities, particularly the standalone management of legacy insurance subsidiaries. |
Legal Proceedings
- The filing mentions 'legal costs related to litigation involving the company's former lifestyle protection insurance business' under discontinued operations.
- The 'Cautionary Note Regarding Forward-Looking Statements' refers to 'the resolution of the appeal or any potential litigation recovery amounts in connection with the AXA S.A. (AXA) and Santander Cards UK Limited (Santander) litigation'.
Stakeholder Impact
- Shareholders: Mixed impact due to strong Enact performance and share repurchases offset by significant losses in the Closed Block LTC segment and overall lower consolidated profitability.
- Customers (CareScout): Benefit from the expansion of the CareScout Quality Network, launch of Care Plans, and new CareScout insurance offerings (Care Assurance).
- Policyholders (Closed Block): Subject to ongoing in-force rate actions, which aim to improve the financial health of the legacy insurance subsidiaries but can result in premium increases or benefit reductions.
- Creditors: Holding company cash and liquid assets decreased, and the cautionary note mentions risks related to capital and financing.
Next Steps
- Genworth will conduct a conference call on February 24, 2026, at 9:00 a.m. (ET) to discuss its fourth quarter 2025 results.
- Enact announced a new share repurchase program with authorization to purchase up to $500 million of common stock.
- Enact announced an excess of loss reinsurance agreement covering the 2027 book year.
- The company plans continued execution against strategic priorities, including advancing CareScout's strategy and disciplined management of legacy insurance businesses.
Key Dates
| Date | Description |
|---|---|
| 2012 | In-force rate actions (IFAs) began, leading to an estimated $34.5 billion net present value achieved. |
| February 28, 2025 | Date of filing of the company's Annual Report on Form 10-K. |
| October 2025 | Company began selling an individual long-term care insurance product through its CareScout Insurance subsidiary and ceased sales through Genworth Life Insurance Company (GLIC). New reportable segments began. Care Assurance launched. |
| December 31, 2025 | End of the fourth quarter 2025, for which financial results are reported. |
| February 23, 2026 | Date of the Current Report on Form 8-K filing, announcing Q4 2025 financial results. |
| February 24, 2026 | Conference call to discuss fourth quarter 2025 results at 9:00 a.m. (ET). |
| February 2026 | Enact announced a new share repurchase program with authorization to purchase up to $500 million of common stock. |
| 2027 | Enact announced an excess of loss reinsurance agreement covering the 2027 book year. |
Recommendation
holdGenworth presents a complex investment case. The Enact mortgage insurance segment is a strong performer, generating significant capital and returning it to shareholders through dividends and share repurchases. The strategic pivot towards CareScout is promising, with new product launches and acquisitions. However, the substantial and worsening losses in the Closed Block long-term care insurance segment, driven by unfavorable experience and assumption updates, continue to be a major drag on consolidated profitability. The decline in holding company cash and overall adjusted operating income quarter-over-quarter indicates ongoing challenges. While the company is actively managing its legacy block and investing in future growth, the persistent issues in LTC create significant uncertainty. A 'Hold' recommendation reflects the balance between the strong, cash-generative Enact business and the strategic growth in CareScout, offset by the material and ongoing liabilities from the Closed Block, which make a 'Buy' difficult despite the share repurchases. Investors should monitor the progress of CareScout and the effectiveness of LTC in-force rate actions.
Keywords
Genworth Financial, GNW, Enact, CareScout, Long-Term Care Insurance, Mortgage Insurance, Annuities, Financial Results, Q4 2025 Earnings, SEC Filing, 8-K, Financial Services, Insurance, PMIERs, RBC Ratio, Share Repurchases, Seniorly Acquisition, Statutory Earnings, Investment Income, Adjusted Operating Income
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.